The largest epidemiological study to date on multidrug-resistant Klebsiella pneumoniae in Saudi hospitals highlights the need ...

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

NDAQ:ACXP) Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI) ...

The team behind the Oxford AstraZeneca covid vaccine say they are developing an injection that could prevent the bubonic ...

The "Antibiotic Resistance Therapeutics Market 2025-2029 - Insights by Pathogen and Therapy Type, with Situation Analysis, Executive, and Investor Guides" report has been added to ...

Resistance development of MRSA has become a global health problem. New resistance types, such as vancomycin-resistant S. aureus, have been recently developed. Novel antibiotics, such as linezolid ...

MRSA is a type of staph highly resistant to a common class of antibiotics. Many people carry MRSA harmlessly on their skin or inside their noses. However, if the bacteria penetrates the skin ...

Inc., a wholly owned subsidiary of Innoviva Inc., for the commercialization of Basilea’s hospital anti-MRSA antibiotic Zevtera (ceftobiprole) in the United States. Innoviva Specialty Therapeutics is a ...

Double whammy antibiotic makes antibiotic resistance much harder—new study Aug 5, 2024 Researchers find degradation of cell wall key in the spread of resistance ...

This marks Zevtera as the sole FDA-approved MRSA-targeting cephalosporin antibiotic for these conditions. It is also indicated for acute bacterial skin and skin structure infections (ABSSSI) and ...